The Effects of Seasonal Changes in Osteoporosis Treatment

Toshihiko Kono

Status: Unknown

Conditions: Selective Estrogen Receptor Modulator (SERM)

Treatments: Drug: Raloxifene

Study type: Observational

Funder types: Other

Identifiers

NCT02977949

TH 05-2

Details and patient eligibility

About

There are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons.

Full description

Vitamin D insufficiency is common in many countries. Vitamin D insufficiency is associated with osteoporosis and the responses to osteoporosis treatment. 25-hydroxyvitamin D (25OHD) is considered to be the best estimate of body stores of vitamin D and the seasonal variation of 25OHD is well known. But there are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons in patients treated by raloxifene.

Enrollment: 200 estimated patients

Sex: Female

Ages: 45 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Postmenopausal women

Exclusion criteria

• Patients who could not use SERM